Digital PCR Market With Worldwide Industry Analysis To 2025

Posted by Mangesh on May 14th, 2019

The Global Digital PCR Market was valued at 8 million in 2017, and is projected to reach ,206 million by 2025, growing at a CAGR of 18.0% from 2018 to 2025. North America was the highest contributor to the digital PCR market in 2017; however, Asia-Pacific is expected to witness the highest growth during the forecast period.

Digital PCR is a simple and reproducible method that does not rely on a calibration curve for sample target quantification. It allows precise, highly sensitive quantification of nucleic acids. It is used for absolute quantification and analysis of minority sequences. This type of PCR enhances the sensitivity of real-time PCR and detects rare events such as single-nucleotide mutations in a population of wild-type sequences. With digital PCR, a sample is partitioned so that individual nucleic acid molecules within the sample are localized and concentrated within many separate regions. After PCR amplification, nucleic acids may be quantified by counting the regions that contain PCR end-product and positive reactions.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/654

The major factors that drive the growth of the digital PCR market are rise in prevalence of infectious disease, increase in awareness and acceptance of personalized medicines, and technological advancements in the field of digital PCR.

The Major key players Are:

•          Bio-Rad Laboratories, Inc. (RainDance Technologies, Inc.)
•          Expedeon AG
•          Fluidigm Corporation
•          JN Medsys
•          Merck KGaA
•          Qiagen N.V. (Formulatrix, Inc.)
•          Stilla Technologies
•          Sysmex Corporation (Sysmex Inostics GmbH)
•          Thermo Fisher Scientific, Inc.

Get a purchase enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/654

However, high cost of digital PCR devices and reimbursement issues limit the market growth. However, increase in funding for R&D activities is anticipated to provide numerous opportunities for the market growth during the forecast period.
Based on technology, the market is bifurcated into droplet digital PCR (ddPCR) and BEAMing digital PCR. The ddPCR segment was the major revenue contributor in 2017, and is anticipated to continue this trend during the forecast period, ddPCR technique provides a precise measure of DNA molecules through each drop. In addition, the massive sample partitioning is a key aspect of the droplet digital PCR technique, which increases the demand.

Depending on type, the market is categorized into digital PCR systems, consumables & reagents, and software & services. The software & services segment is projected to experience rapid growth during the forecast period, as the software helps improve the efficiency of management of digital PCR data and thus, rise in demand for these products propels the market growth.

North America was the leading revenue contributor to the global digital polymerase chain reaction market in 2017, and is expected to remain dominant throughout the forecast period. This is attributed to its well-developed healthcare industry, presence of leading molecular diagnostics manufacturers in the region, and rise in number of patients using personalized medicines. However, Asia-Pacific is expected to grow at the highest CAGR of 19.1% during the study period, as it offers lucrative opportunities for the molecular diagnostics players due to increase in number of patients suffering from chronic diseases and improvement in healthcare facilities in the region.

Key Findings of the Digital PCR Market:

• Based on application, the forensics segment is projected to grow at the highest rate during the analysis period.
• North America dominated the global digital PCR market in 2017 and is projected to continue its dominance in future.
• China is expected to grow at the highest rate in Asia-Pacific during the forecast period.
• Based on product type, consumables and reagents was the largest contributor in 2017.
• Based on technology, the ddPCR segment generated the highest revenue and is expected to continue its dominance in future.